Perforomist Shortage Update: What Patients Need to Know in 2026

If you or a loved one depends on Perforomist (formoterol fumarate inhalation solution) to manage COPD, you may have noticed it's not always easy to find at your local pharmacy. Here's what you need to know about Perforomist availability in 2026 — including whether there's an active shortage, what's causing supply issues, and what you can do if your pharmacy is out of stock.

Is Perforomist on the FDA Drug Shortage List in 2026?

As of 2026, formoterol fumarate inhalation solution (Perforomist) is not on the FDA's official Drug Shortage List. The FDA tracks shortages when supply is critically impacted nationwide. The fact that Perforomist isn't on the list is good news — it means supply exists in the national distribution chain.

However, "not in shortage" doesn't mean easy to find at your corner pharmacy. Patients across the country continue to report that their local pharmacies don't stock it regularly — and that's a real problem for those who need it daily.

What Causes Perforomist Availability Problems?

Several structural factors make Perforomist harder to find than common oral medications:

• Low retail demand: Nebulized LABAs serve a smaller patient population than oral or MDI medications. Most pharmacies don't see enough Perforomist prescriptions to justify keeping large stock.
• Refrigeration requirements: Unit-dose vials must be stored at 36°F–46°F, which adds inventory complexity and cost for pharmacies.
• Insurance switching pressure: At a retail price of $865–$1,484 for a 30-day supply, insurers and PBMs aggressively steer patients to alternatives, reducing demand for Perforomist specifically.
• Generic market complexity: Generic formoterol fumarate inhalation solution is available from multiple manufacturers. Pharmacies may carry one manufacturer's generic but not another — causing confusion about what's 'in stock.'

Historical Shortage Context

Perforomist has not faced the kind of dramatic, headline-grabbing shortages that some other medications have in recent years. Its availability issues are more chronic and structural in nature — less of an acute crisis and more of an ongoing challenge for the specific patients who need a nebulized LABA for COPD. This distinction matters because the solutions are different: it's about finding the right pharmacy, not waiting for a supply chain to recover.

What Patients Should Do Right Now

If you're having trouble finding Perforomist, here are immediate steps:

1. Don't skip doses. Missing Perforomist doses can worsen COPD symptoms and trigger exacerbations. This is a medical priority.
2. Contact your prescriber immediately. They need to know you can't find your medication. They can help locate it or prescribe an appropriate bridge alternative.
3. Use medfinder.

medfinder calls pharmacies near you to find which ones can fill your Perforomist prescription, saving you hours of phone calls.

1. Ask about generic formoterol fumarate. The generic version is therapeutically equivalent and may be stocked where brand Perforomist is not.
2. Consider specialty or mail-order pharmacy. Specialty pharmacies like CVS Specialty often have more reliable Perforomist stock and can deliver directly to you.

37,599+ patients found their medications in stock

37K+

Find Perforomist In Stock Today →

Key Takeaway

Perforomist is not in a declared national shortage in 2026, but localized stocking challenges persist. The solution is persistence — calling multiple pharmacies, using services like medfinder, and talking to your prescriber. Read more about

why Perforomist is hard to find and explore

alternatives to Perforomist if needed.